Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2025-12-24 @ 7:16 PM
NCT ID:
NCT06818903
Eligibility Criteria:
Inclusion Criteria:
* Women aged between 18 - 40 years of age with mid-trimester fetal death inutero.
* Singleton pregnancies from 18-24 weeks.
* women with unfavourable cervix (Bishop Score \< 5) at the time of recruitment.
* Previous one CS and non-previous CS pregnant women.
Exclusion Criteria:
* • Previous 2 CS or more.
* Medical contraindications for prostaglandin therapy (allergy to prostaglandins or severe asthma).
* co-morbidities like severe anemia (Hb \< 7g/dl), hypertension, diabetes, or coagulopathy .
* Women with excessive vaginal discharge or rupture of membrane.
* Women having any complication in previous caesarean like endometritis, reopening, scar dehiscence etc.
* Active genital infection e. g. active genital Herpes simplex infection.
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT06818903
Study Brief:
Protocol Section:
NCT06818903